IP Library Granted Patent US 7,813,780
Granted Patent B2
US 7,813,780 · App. 11/301,512 · Granted Oct 12, 2010

Biosensors and methods for making and using them

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,813,780
App. No.
11/301,512
Granted
Oct 12, 2010
Kind
B2
Abstract

Embodiments of the invention provide analyte sensors having optimized permselective membranes and methods for making and using such sensors. Embodiments of the invention also provide analyte sensors such as those having porous matrices coated with an analyte sensing composition and methods for making and using such sensors. Illustrative embodiments include electrochemical glucose sensors having glucose oxidase coatings.

Claims (22)

1. A membrane for use with an implantable analyte sensor comprising:

a first layer comprising a biocompatible polymer composition that is:

impermeable to immunoglobulins; and

permeable to oxygen, glucose and lactate; and

a second layer coupled to the first layer, the second layer comprising a plurality of pores disposed therein and wherein at least one of the plurality of pores disposed in the second layer contains functionalized poly(dimethyl siloxane), functionalized poly(dimethyl siloxane) copolymer or a mixture of functionalized poly(dimethyl siloxane) and functionalized poly(dimethyl siloxane) copolymer of the second layer,

wherein the membrane is more permeable to oxygen than glucose and/or lactate.

2. The membrane of claim 1 , wherein the first layer comprises a plurality of pores disposed therein.

3. The membrane of claim 2 , wherein the average diameter of the plurality of pores is between 2 microns and 40 microns.

4. The membrane of claim 2 , wherein the average depth of the plurality of pores is between 50 microns and 250 microns.

5. The membrane of 2 , wherein the implantable analyte sensor is a glucose sensor that comprises a layer of glucose oxidase and further wherein the size of the pores is controlled to optimize the relative concentrations of glucose and oxygen that react with the glucose oxidase.

6. The membrane of 2 , wherein the implantable analyte sensor is a glucose sensor that comprises a layer of glucose oxidase and further wherein the geometry of the pores is controlled to optimize the relative concentrations of glucose and oxygen that react with the glucose oxidase.

7. The membrane of claim 1 , further comprising an adhesive layer disposed between the first and second layers, wherein the adhesive layer promotes adhesion between the first and second layers.

8. A membrane for use with an implantable analyte sensor comprising:

a first layer comprising a biocompatible polymer composition that is:

impermeable to immunoglobulins; and

permeable to oxygen, glucose and lactate; and

a second layer coupled to the first layer comprising functionalized poly(dimethyl siloxane), functionalized poly(dimethyl siloxane) copolymer or a mixture of functionalized poly(dimethyl siloxane) and functionalized poly(dimethyl siloxane) copolymer,

wherein the membrane is more permeable to oxygen than glucose and/or lactate, and wherein the first or second layer comprises a plurality of pores disposed therein and further wherein at least one of the plurality of pores contains a biocompatible hydrophilic polymer that facilitates hydration of the implantable analyte sensor.

9. The membrane of claim 8 , wherein the hydrophilic polymer comprises an ethylene glycol or propylene glycol block copolymer or a mixture thereof.

10. The membrane of claim 8 , wherein the hydrophilic polymer is a hydrogel.

11. The membrane of claim 8 , wherein the biocompatible hydrophilic polymer enhances the wetting of a component in the sensor via capillary action.

12. The membrane of claim 8 , wherein the biocompatible hydrophilic polymer is selectively disposed in a subset of the plurality of pores, wherein the subset of the plurality pores have a diameter or depth that is at least 10%, 20%, 30%, 40% or 50% larger than the average diameter of the plurality of pores or at least 10%, 20%, 30%, 40% or 50% larger than the average depth of the plurality of pores.

Assignments (1)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →